Silicon Laboratories Inc. (NASDAQ:SLAB) Given Average Recommendation of “Moderate Buy” by Analysts

Silicon Laboratories Inc. (NASDAQ:SLAB) has received an average recommendation of “Moderate Buy” from the ten brokerages that are presently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $121.50.

Several research firms recently weighed in on SLAB. Morgan Stanley reduced their target price on shares of Silicon Laboratories from $123.00 to $97.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 5th. Stifel Nicolaus reduced their price objective on Silicon Laboratories from $160.00 to $135.00 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Barclays lowered their target price on Silicon Laboratories from $120.00 to $75.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 5th. JPMorgan Chase & Co. reduced their price target on Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 5th. Finally, StockNews.com upgraded Silicon Laboratories to a “sell” rating in a report on Friday, November 8th.

Silicon Laboratories Price Performance

Shares of NASDAQ:SLAB opened at $110.65 on Wednesday. The firm has a market capitalization of $3.59 billion, a PE ratio of -14.95 and a beta of 1.20. Silicon Laboratories has a 12 month low of $94.00 and a 12 month high of $154.91. The business has a 50-day moving average of $110.92 and a two-hundred day moving average of $113.48.

Silicon Laboratories (NASDAQ:SLAB) last posted its earnings results on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.07. The firm had revenue of $166.00 million during the quarter, compared to the consensus estimate of $165.50 million. Silicon Laboratories had a negative net margin of 46.93% and a negative return on equity of 12.60%. The company’s revenue was down 18.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.48 EPS. As a group, research analysts anticipate that Silicon Laboratories will post -3.56 earnings per share for the current year.

Insider Transactions at Silicon Laboratories

In related news, SVP Brandon Tolany sold 845 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $115.00, for a total transaction of $97,175.00. Following the sale, the senior vice president now directly owns 43,615 shares of the company’s stock, valued at approximately $5,015,725. This represents a 1.90 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 1.72% of the company’s stock.

Institutional Trading of Silicon Laboratories

Several institutional investors have recently added to or reduced their stakes in SLAB. Wellington Management Group LLP raised its position in shares of Silicon Laboratories by 28.3% during the 3rd quarter. Wellington Management Group LLP now owns 888,382 shares of the semiconductor company’s stock worth $102,670,000 after purchasing an additional 195,997 shares during the period. Clearbridge Investments LLC increased its position in Silicon Laboratories by 84.0% in the second quarter. Clearbridge Investments LLC now owns 273,776 shares of the semiconductor company’s stock worth $30,288,000 after buying an additional 125,022 shares during the period. American Century Companies Inc. lifted its stake in Silicon Laboratories by 29.5% in the second quarter. American Century Companies Inc. now owns 316,407 shares of the semiconductor company’s stock valued at $35,004,000 after buying an additional 72,138 shares during the last quarter. Point72 Asset Management L.P. acquired a new position in shares of Silicon Laboratories during the third quarter valued at $7,408,000. Finally, FMR LLC boosted its holdings in shares of Silicon Laboratories by 1.1% during the third quarter. FMR LLC now owns 4,843,370 shares of the semiconductor company’s stock valued at $559,748,000 after acquiring an additional 54,708 shares during the period.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.